Effective treatment of refractory lichen planus pemphigoides with a Janus kinase-1/2 inhibitor.
Anthony MoussaThemis Getsos CollaLella AsfourBevin BhoyrulRodney Daniel SinclairPublished in: Clinical and experimental dermatology (2022)
Lichen planus pemphigoides is a rare autoimmune subepidermal blistering disease clinically and histopathologically characterized by features of lichen planus and bullous pemphigoid. We describe a case of refractory lichen planus pemphigoides successfully treated with the selective and reversible Janus kinase-1/2 inhibitor, baricitinib.
Keyphrases